Search

Search Constraints

You searched for: Author/Creator Rosner, Inger

Search Results

1. Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer. (23rd October 2020)

2. Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration‐resistant prostate cancer. (19th February 2016)

3. Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies. Issue 3 (18th September 2021)